We are live on ! Find out more
Bank of New York Mellon

Bank of New York Mellon Portfolio holdings

AUM $609B
1-Year Est. Return 40.19%
 

Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.

This Fund
S&P 500
This Quarter Est. Return
+24.16%
1 Year Est. Return
+40.19%
3 Year Est. Return
+118.86%
5 Year Est. Return
+156%
10 Year Est. Return
+606.23%
AUM
$375B
AUM Growth
+$72.8B
Cap. Flow
+$9.25B
Cap. Flow %
2.47%
Top 10 Hldgs %
20.56%
Holding
4,266
New
170
Increased
1,923
Reduced
1,788
Closed
190

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$478M
2
RTN
Raytheon Company
RTN
+$318M
3
MRK icon
Merck
MRK
+$257M
4
JNJ icon
Johnson & Johnson
JNJ
+$251M
5
QCOM icon
Qualcomm
QCOM
+$240M

Sector Composition

Rank Sector Weight
1 Technology 24.55%
2 Healthcare 13.79%
3 Financials 11.38%
4 Consumer Discretionary 10.81%
5 Industrials 8.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LMST
3676
DELISTED
Limestone Bancorp, Inc. Common Stock
LMST
$182K ﹤0.01%
+13,815
New +$167K
PHAS
3677
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$182K ﹤0.01%
39,756
-1,495
-4% -$6.62K
NWHM
3678
DELISTED
THE NEW HOME COMPANY INC.
NWHM
$181K ﹤0.01%
53,805
-216
-0.4% -$568
BW icon
3679
Babcock & Wilcox
BW
$1.39B
$180K ﹤0.01%
78,845
-61,184
-44% -$106K
CKPT
3680
DELISTED
Checkpoint Therapeutics
CKPT
$180K ﹤0.01%
9,073
+3,527
+64% +$64.3K
JGH icon
3681
Nuveen Global High Income Fund
JGH
$356M
$179K ﹤0.01%
+13,490
New +$169K
TWIN icon
3682
Twin Disc
TWIN
$349M
$179K ﹤0.01%
32,196
-35,559
-52% -$207K
HALL
3683
DELISTED
Hallmark Financial Services, Inc.
HALL
$179K ﹤0.01%
5,142
-4,030
-44% -$135K
ABTC
3684
American Bitcoin Corp
ABTC
$533M
$178K ﹤0.01%
+1
New +$252K
PTRS
3685
DELISTED
Partners Bancorp Common Stock
PTRS
$178K ﹤0.01%
+27,055
New +$189K
HYRE
3686
DELISTED
HyreCar Inc. Common Stock
HYRE
$178K ﹤0.01%
60,669
ACRS icon
3687
Aclaris Therapeutics
ACRS
$863M
$176K ﹤0.01%
109,213
-108,570
-50% -$145K
BLE
3688
DELISTED
BlackRock Municipal Income Trust II
BLE
$175K ﹤0.01%
11,901
-60
-0.5% -$824
SB icon
3689
Safe Bulkers
SB
$781M
$175K ﹤0.01%
143,826
-1,493
-1% -$1.64K
TRAK icon
3690
ReposiTrak
TRAK
$158M
$175K ﹤0.01%
41,386
+28,824
+229% +$139K
BXMX
3691
DELISTED
Nuveen S&P 500 Buy-Write Income Fund
BXMX
$174K ﹤0.01%
15,792
-682
-4% -$7.42K
KLXE icon
3692
KLX Energy Services
KLXE
$36M
$174K ﹤0.01%
16,211
-38,250
-70% -$304K
SLNO
3693
DELISTED
Soleno Therapeutics
SLNO
$173K ﹤0.01%
+5,179
New +$224K
SYBX
3694
DELISTED
Synlogic
SYBX
$173K ﹤0.01%
5,696
-2,648
-32% -$84.6K
MBII
3695
DELISTED
Marrone Bio Innovations, Inc.
MBII
$173K ﹤0.01%
147,682
+39,939
+37% +$36.9K
NL icon
3696
NLI Holdings
NL
$319M
$172K ﹤0.01%
50,379
-219
-0.4% -$679
GRTX
3697
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$172K ﹤0.01%
24,131
+12,535
+108% +$133K
PAVM icon
3698
PAVmed
PAVM
$33.9M
$170K ﹤0.01%
+179
New +$179K
FSK icon
3699
FS KKR Capital
FSK
$3.49B
$168K ﹤0.01%
11,969
-83,593
-87% -$1.18M
ITRN icon
3700
Ituran Location and Control
ITRN
$1.06B
$168K ﹤0.01%
10,468
-3,107
-23% -$51.2K

Similar funds

Bank of New York Mellon's Q2 2020 Portfolio in Review

As of Q2 2020, Bank of New York Mellon held 4,266 positions worth $375B, up 24% from $302B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Bank of New York Mellon's Q2 2020 filing shows 170 new, 1,923 increased, 1,788 reduced and 190 closed positions. Its largest new stake was Otis Worldwide: 5,903,383 shares worth $336M. The largest sale was Allergan plc, an estimated $478M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

  • Bank of New York Mellon's largest Q2 2020 buy was Otis Worldwide: 5,903,383 shares worth $336M.
  • Bank of New York Mellon added most to Amazon in Q2 2020, an estimated $1.7B increase.
  • Bank of New York Mellon's biggest Q2 2020 reduction was Merck, cutting an estimated $257M.
  • Bank of New York Mellon fully exited Allergan plc in Q2 2020, selling an estimated $478M.
  • Bank of New York Mellon's ten largest holdings make up 21% of its $375B portfolio in Q2 2020.
  • Bank of New York Mellon opened 170 new positions and closed 190 in Q2 2020.
  • Bank of New York Mellon's portfolio value rose 24% quarter-over-quarter to $375B.

Based on Bank of New York Mellon's 13F filing for Q2 2020, filed 12 Aug 2020.